| Autor: |
Olakunde BO; Department of Community Prevention and Care Services, 434818National Agency for the Control of AIDS, Abuja, Nigeria.; Center for Translation and Implementation Research, University of Nigeria, Nsukka, Nigeria., Adeyinka DA; Department of Public Health, National AIDS and STI Control Programme, Federal Ministry of Health, Abuja, Nigeria.; Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada., Ndukwe CD; Department of Community Prevention and Care Services, 434818National Agency for the Control of AIDS, Abuja, Nigeria.; African Institute of Health Policy and Health Systems, Abakaliki, Nigeria., Oladele TT; Department of Community Prevention and Care Services, 434818National Agency for the Control of AIDS, Abuja, Nigeria., Yahaya HB; Department of Community Prevention and Care Services, 434818National Agency for the Control of AIDS, Abuja, Nigeria., Ijaodola OA; Department of Public Health, National AIDS and STI Control Programme, Federal Ministry of Health, Abuja, Nigeria. |
| Abstrakt: |
Nigeria has adopted routine screening of pregnant women for hepatitis B virus (HBV) as part of the interventions to eliminate its vertical transmission. However, there is a dearth of evidence on the coverage of routine antenatal HBV screening as recommended in the national guidelines. This study examined the antenatal HBV screening rate and the positivity rate compared with syphilis and HIV. We conducted a descriptive analysis of the 2019 national HIV/AIDS health sector data. The study included approximately 2.8 million pregnant women who received antenatal care (ANC) in over 6000 health facilities providing prevention of mother-to-child transmission of HIV services in Nigeria. Of the ANC clients, 0.2 million (7.2%) were screened for HBV. At the zonal level, the South West had the highest HBV screening rate (19%), while the lowest rate was in the North East (2.5%). The percentage of pregnant women screened for HBV was lower than those screened for syphilis (16.3%) and HIV (90.3%). Among those screened for HBV, the positivity rate was 5%. The HBV positivity rate ranged from 8.5% in the North Central zone to 1.3% in the South East zone. The positivity rates for syphilis and HIV were 0.4% and 0.5%, respectively. Our results indicate a low antenatal HBV screening rate and a wide disparity compared with HIV and syphilis. This finding highlights the need to understand and address the barriers affecting routine antenatal HBV screening and to strengthen the integration of HBV services into the HIV program in Nigeria. |
